Berg D - Search Results

1

The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D. Gaenslen A, et al. Among authors: berg d. Lancet Neurol. 2008 May;7(5):417-24. doi: 10.1016/S1474-4422(08)70067-X. Epub 2008 Apr 3. Lancet Neurol. 2008. PMID: 18394965 Clinical Trial.

2

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound.

Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW. Berg D, et al. Neurology. 1999 Sep 22;53(5):1026-31. doi: 10.1212/wnl.53.5.1026. Neurology. 1999. PMID: 10496262

3

Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging.

Berg D, Supprian T, Hofmann E, Zeiler B, Jäger A, Lange KW, Reiners K, Becker T, Becker G. Berg D, et al. J Neurol. 1999 Dec;246(12):1186-93. doi: 10.1007/s004150050541. J Neurol. 1999. PMID: 10653314

4

Relationship of substantia nigra echogenicity and motor function in elderly subjects.

Berg D, Siefker C, Ruprecht-Dörfler P, Becker G. Berg D, et al. Neurology. 2001 Jan 9;56(1):13-7. doi: 10.1212/wnl.56.1.13. Neurology. 2001. PMID: 11148229

5

Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound.

Becker G, Berg D. Becker G, et al. Among authors: berg d. Mov Disord. 2001 Jan;16(1):23-32. doi: 10.1002/1531-8257(200101)16:1<23::aid-mds1003>3.0.co;2-2. Mov Disord. 2001. PMID: 11215589 Review.

6

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.

Berg D, Siefker C, Becker G. Berg D, et al. J Neurol. 2001 Aug;248(8):684-9. doi: 10.1007/s004150170114. J Neurol. 2001. PMID: 11569897 Clinical Trial.

7

Perspectives of B-mode transcranial ultrasound.

Berg D, Becker G. Berg D, et al. Neuroimage. 2002 Mar;15(3):463-73. doi: 10.1006/nimg.2001.1014. Neuroimage. 2002. PMID: 11848690 Review.

8

Does ultrasound disclose a vulnerability factor for Parkinson's disease?

Behnke S, Berg D, Becker G. Behnke S, et al. Among authors: berg d. J Neurol. 2003 Feb;250 Suppl 1:I24-7. doi: 10.1007/s00415-003-1104-0. J Neurol. 2003. PMID: 12761631 Review.

9

Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.

Hering R, Petrovic S, Mietz EM, Holzmann C, Berg D, Bauer P, Woitalla D, Müller T, Berger K, Krüger R, Riess O. Hering R, et al. Among authors: berg d. Neurology. 2004 Apr 13;62(7):1231-2. doi: 10.1212/01.wnl.0000118285.18383.90. Neurology. 2004. PMID: 15079038 No abstract available.

10

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.

Berg D, Merz B, Reiners K, Naumann M, Becker G. Berg D, et al. Mov Disord. 2005 Mar;20(3):383-5. doi: 10.1002/mds.20311. Mov Disord. 2005. PMID: 15486999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,424 results

Search Page

Filters